Gold Health Tech Gold Health Tech
search
Available for inquiry Specification-led inquiry

Medical equipment sourcing

Bladder Cancer Test Kit

Reference: 760529Laboratory Medicine
Sample TypeUrine
ApplicationsBladder Cancer
Analysis ModeEnzyme Immunoassay
manage_search

Product fit review

Compare the available product information with your application and purchasing requirements.

description

Documentation request

Ask which specifications, manuals, or commercial documents are available for review.

support_agent

Supplier coordination

Discuss quantity, destination, packaging, and timing before confirming suitability.

Product information

Product summary

The Alere NMP22® Test Kit is an enzyme immunoassay (EIA) that is designed to quantify the nuclear mitotic apparatus protein (NuMA) in stabilized voided urine in vitro. NuMA is a prevalent component of the nuclear matrix proteins.Advantagesinput:
output:Nuclear Matrix Protein 22 is a protein that is ubiquitous in the nucleus of all cells. NMP22 is released into urine by bladder cancer cells. An NMP22-specific assay can detect elevated levels of NMP22 at the earliest stages of the disease, rendering it a marker for early diagnosis and monitoring in conjunction with standard diagnostic procedures.Oneinput:
output:The key to enhancing the likelihood of survival is the early detection of bladder cancer. Our test is a complementary procedure to cystoscopy that has enhanced the combined detection rate of bladder cancer and has a generally higher sensitivity than cytology.Two

Continue your equipment review

Related products